StockData
Liquidia Corp logo

Liquidia Corp (LQDA) stock

LQDANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/3075% above fair value
$56.40−0.33 (-0.58%)

Close on Nov 18, 2026Market cap $5.05BP/E 40.6Yield –

Liquidia revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Liquidia's revenue for the twelve months ending Jun 30, 2026 was $450.91M, up 2233.6% year over year. For fiscal 2025 it was $158.32M, up 1031.2% from the year before. The highest annual figure on record is $158.32M in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$158.32M+1031.2%
FY2024Dec 31, 2024$14.00M-20.0%
FY2023Dec 31, 2023$17.49M+9.7%
FY2022Dec 31, 2022$15.94M+24.0%
FY2021Dec 31, 2021$12.85M+1637.8%
FY2020Dec 31, 2020$739.63K-90.8%
FY2019Dec 31, 2019$8.07M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$171.68M+1842.7%
Q1 FY2026Mar 31, 2026$132.87M+4158.5%
Q4 FY2025Dec 31, 2025$92.02M+3054.6%
Q3 FY2025Sep 30, 2025$54.34M+1121.7%
Q2 FY2025Jun 30, 2025$8.84M+141.5%
Q1 FY2025Mar 31, 2025$3.12M+5.0%
Q4 FY2024Dec 31, 2024$2.92M-35.6%
Q3 FY2024Sep 30, 2024$4.45M+20.9%
Q2 FY2024Jun 30, 2024$3.66M-23.5%
Q1 FY2024Mar 31, 2024$2.97M-33.9%
Q4 FY2023Dec 31, 2023$4.53M-15.5%
Q3 FY2023Sep 30, 2023$3.68M+16.2%
Q2 FY2023Jun 30, 2023$4.79M+22.2%
Q1 FY2023Mar 31, 2023$4.49M+28.7%
Q4 FY2022Dec 31, 2022$5.36M+66.7%
Q3 FY2022Sep 30, 2022$3.17M-0.4%
Q2 FY2022Jun 30, 2022$3.92M+16.1%
Q1 FY2022Mar 31, 2022$3.49M+13.2%
Q4 FY2021Dec 31, 2021$3.22M+334.7%
Q3 FY2021Sep 30, 2021$3.18M–
Q2 FY2021Jun 30, 2021$3.38M–
Q1 FY2021Mar 31, 2021$3.08M–
Q4 FY2020Dec 31, 2020$739.63K–
Q3 FY2020Sep 30, 2020$0–
Q2 FY2020Jun 30, 2020$0–
Q1 FY2020Mar 31, 2020$0–

More Liquidia figures

See a number that looks wrong?